Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Urinary Bladder"" wg kryterium: Temat


Tytuł:
Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer?
Autorzy:
Yanagisawa T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Sato S; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan.
Hayashida Y; Department of Urology, National Hospital Organization Ureshino Medical Center, Saga, Japan.
Okada Y; Department of Urology, Saitama Medical Center, Saitama, Japan.
Iwatani K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Matsukawa A; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Takahashi H; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan.
Egawa S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.; Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic.; Department of Urology, Weill Cornell Medical College, New York, NY, USA.; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria.
Miki J; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2023 Feb; Vol. 131 (2), pp. 190-197. Date of Electronic Publication: 2022 May 13.
Typ publikacji:
Journal Article
MeSH Terms:
Margins of Excision*
Urinary Bladder Neoplasms*/surgery
Urinary Bladder Neoplasms*/pathology
Humans ; Retrospective Studies ; Urinary Bladder/pathology ; Urologic Surgical Procedures ; Neoplasm Recurrence, Local/pathology
Czasopismo naukowe
Tytuł:
Oncological validation and discriminative ability of pentafecta criteria after open radical cystectomy.
Autorzy:
von Deimling M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Rink M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Klemm J; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Koelker M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
König F; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Gild P; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Khonsari M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Urologikum Hamburg MVZ Alstertal, Hamburg, Germany.
Ludwig TA; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Marks P; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Dahlem R; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Fisch M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Vetterlein MW; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2023 Jan; Vol. 131 (1), pp. 90-100. Date of Electronic Publication: 2022 Sep 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Urinary Bladder Neoplasms*/pathology
Urinary Diversion*
Humans ; Cystectomy/adverse effects ; Treatment Outcome ; Urinary Bladder/pathology ; Retrospective Studies
Czasopismo naukowe
Tytuł:
The influence of multidisciplinary team meetings on treatment decisions in advanced bladder cancer.
Autorzy:
Walraven JEW; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.
Ripping TM; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.
Oddens JR; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
van Rhijn BWG; Department of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Goossens-Laan CA; Department of Urology, Alrijne Hospital, Leiderdorp, the Netherlands.
Hulshof MCCM; Department of Radiotherapy, Amsterdam University Medical Centers, VU Medical Center, Amsterdam, the Netherlands.
Kiemeney LA; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands.
Lemmens VEPP; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.
van der Hoeven JJM; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.
Desar IME; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
Aben KKH; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Verhoeven RHA; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.; Department of Medical Oncology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
Pokaż więcej
Corporate Authors:
BlaZIB Study Group
Źródło:
BJU international [BJU Int] 2023 Feb; Vol. 131 (2), pp. 244-252. Date of Electronic Publication: 2022 Aug 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Urinary Bladder Neoplasms*/surgery
Humans ; Aged, 80 and over ; Urinary Bladder/pathology ; Cystectomy ; Neoadjuvant Therapy ; Patient Care Team ; Neoplasm Invasiveness
Czasopismo naukowe
Tytuł:
Do men with bladder stones benefit from treatment of benign prostatic obstruction?
Autorzy:
Maresca G; Department of Urology, Aberdeen Royal Infirmary - NHS Grampian, Aberdeen, UK.; Academic Urology Unit (AUU), University of Aberdeen, Aberdeen, UK.
Mc Clinton S; Department of Urology, Aberdeen Royal Infirmary - NHS Grampian, Aberdeen, UK.; Academic Urology Unit (AUU), University of Aberdeen, Aberdeen, UK.
Swami S; Department of Urology, Aberdeen Royal Infirmary - NHS Grampian, Aberdeen, UK.; Academic Urology Unit (AUU), University of Aberdeen, Aberdeen, UK.
El-Mokadem I; Department of Urology, Aberdeen Royal Infirmary - NHS Grampian, Aberdeen, UK.; Academic Urology Unit (AUU), University of Aberdeen, Aberdeen, UK.
Donaldson JF; Department of Urology, Aberdeen Royal Infirmary - NHS Grampian, Aberdeen, UK.; Academic Urology Unit (AUU), University of Aberdeen, Aberdeen, UK.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2022 Nov; Vol. 130 (5), pp. 619-627. Date of Electronic Publication: 2022 May 17.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Hyperplasia*/complications
Prostatic Hyperplasia*/surgery
Prostatic Hyperplasia*/diagnosis
Urinary Bladder Calculi*/surgery
Urinary Bladder Neck Obstruction*/etiology
Urinary Bladder Neck Obstruction*/surgery
Urethral Obstruction*
Lower Urinary Tract Symptoms*/etiology
Lower Urinary Tract Symptoms*/surgery
Lower Urinary Tract Symptoms*/diagnosis
Humans ; Male ; Female ; Retrospective Studies ; Urinary Bladder
Czasopismo naukowe
Tytuł:
Long-term renal function in patients with chronic kidney disease following radical cystectomy and orthotopic neobladder.
Autorzy:
Ahmadi H; Department of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Reddy S; Department of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Nguyen C; Department of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Douglawi A; Department of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Ladi-Seyedian S; Department of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Roberts S; Department of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Ghoreifi A; Department of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Ghodoussipour S; Division of Urology, Department of Surgery, Rutgers Cancer Institute of New Jersey, Rutgers New Jersey Medical School, Newark, NJ, USA.
Bhanvadia SK; Department of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Djaladat H; Department of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Schuckman A; Department of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Daneshmand S; Department of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2022 Aug; Vol. 130 (2), pp. 200-207. Date of Electronic Publication: 2022 Jan 27.
Typ publikacji:
Journal Article
MeSH Terms:
Renal Insufficiency, Chronic*
Urinary Bladder Neoplasms*/surgery
Urinary Diversion*
Cystectomy ; Glomerular Filtration Rate ; Humans ; Kidney/physiology ; Kidney/surgery ; Retrospective Studies ; Urinary Bladder/surgery
Czasopismo naukowe
Tytuł:
Role of blue-light cystoscopy in detecting invasive bladder tumours: data from a multi-institutional registry.
Autorzy:
Ahmadi H; Department of Urology, USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Ladi-Seyedian SS; Department of Urology, USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Konety B; University of Minnesota, Minneapolis, MN, USA.
Pohar K; Ohio State University, Columbus, OH, USA.
Holzbeierlein JM; University of Kansas, Kansas City, KS, USA.
Kates M; The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA.
Willard B; Lexington Medical Center, Lexington, SC, USA.
Taylor JM; Michael E. DeBakey VAMC, BCM, Houston, TX, USA.
Liao JC; VA Palo Alto Health Care System, Palo Alto, CA, USA.
Kaimakliotis HZ; Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA.
Porten SP; Department of Urology, University of California San Francisco, San Francisco, CA, USA.
Steinberg GD; Department of Urology, New York University, New York, NY, USA.
Tyson MD; Department of Urology, Mayo Clinic Hospital, Phoenix, AZ, USA.
Lotan Y; UT Southwestern Medical Center, Dallas, TX, USA.
Daneshmand S; Department of Urology, USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Pokaż więcej
Corporate Authors:
Blue Light Cystoscopy with Cysview Registry Group
Źródło:
BJU international [BJU Int] 2022 Jul; Vol. 130 (1), pp. 62-67. Date of Electronic Publication: 2021 Oct 26.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Cystoscopy*
Urinary Bladder Neoplasms*/surgery
Cystectomy ; Humans ; Registries ; Urinary Bladder/pathology
Czasopismo naukowe
Tytuł:
Contemporary outcomes of bladder carcinoma in situ treated with an adequate bacille Calmette-Guérin immunotherapy.
Autorzy:
Subiela JD; Urooncology Unit, Department of Urology, Fundació Puigvert, Department of Surgery, Universitat Autònoma de Barcelona, Barcelona, Spain.; Oncological and Functional Bladder Pathology Unit, Department of Urology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Madrid, Spain.
Rodríguez Faba Ó; Urooncology Unit, Department of Urology, Fundació Puigvert, Department of Surgery, Universitat Autònoma de Barcelona, Barcelona, Spain.
Aumatell J; Urooncology Unit, Department of Urology, Fundació Puigvert, Department of Surgery, Universitat Autònoma de Barcelona, Barcelona, Spain.
Calderón J; Urooncology Unit, Department of Urology, Fundació Puigvert, Department of Surgery, Universitat Autònoma de Barcelona, Barcelona, Spain.
Mercadé A; Urooncology Unit, Department of Urology, Fundació Puigvert, Department of Surgery, Universitat Autònoma de Barcelona, Barcelona, Spain.
Balañà J; Urooncology Unit, Department of Urology, Fundació Puigvert, Department of Surgery, Universitat Autònoma de Barcelona, Barcelona, Spain.
Esquinas C; Statistics Unit, Department of Urology, Fundació Puigvert, Department of Surgery, Universitat Autònoma de Barcelona, Barcelona, Spain.
Algaba F; Department of Pathology, Fundació Puigvert, Department of Surgery, Universitat Autònoma de Barcelona, Barcelona, Spain.
Breda A; Urooncology Unit, Department of Urology, Fundació Puigvert, Department of Surgery, Universitat Autònoma de Barcelona, Barcelona, Spain.
Palou J; Urooncology Unit, Department of Urology, Fundació Puigvert, Department of Surgery, Universitat Autònoma de Barcelona, Barcelona, Spain.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2022 Apr; Vol. 129 (4), pp. 542-550. Date of Electronic Publication: 2021 Aug 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma in Situ*/drug therapy
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/pathology
Adjuvants, Immunologic/therapeutic use ; Administration, Intravesical ; BCG Vaccine/therapeutic use ; Female ; Humans ; Immunologic Factors/therapeutic use ; Immunotherapy ; Male ; Neoplasm Invasiveness ; Retrospective Studies ; Urinary Bladder/pathology
Czasopismo naukowe
Tytuł:
Caveats in the diagnosis of suspected non-endemic verrucous carcinoma in the urinary bladder.
Autorzy:
Leunbach TL; Department of Urology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Health, Aarhus University, Aarhus, Denmark.
Stilling C; Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark.
Tabor MB; Institute of Pathology, Viborg Regional Hospital, Aarhus, Denmark.
Bjerggaard Jensen J; Department of Urology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Health, Aarhus University, Aarhus, Denmark.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2022 Apr; Vol. 129 (4), pp. 457-459.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Verrucous*/diagnosis
Carcinoma, Verrucous*/pathology
Urinary Bladder Neoplasms*/surgery
Cystectomy ; Female ; Humans ; Male ; Urinary Bladder/pathology
Czasopismo naukowe
Tytuł:
Bladder cancer risk variants and overall and disease-specific survival in two independent cohorts.
Autorzy:
Leeming RC; Department of Epidemiology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
Karagas MR; Department of Epidemiology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
Zens MS; Department of Epidemiology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
Schned AR; Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Seigne JD; Section of Urology, Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Passarelli MN; Department of Epidemiology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2022 Mar; Vol. 129 (3), pp. 309-311. Date of Electronic Publication: 2021 Nov 28.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Transitional Cell*
Urinary Bladder Neoplasms*
Female ; Humans ; Male ; Prognosis ; Urinary Bladder
Czasopismo naukowe
Tytuł:
Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt test.
Autorzy:
Lebret T; Urology Department, Foch Hospital, Suresnes, France.; UVSQ, Paris Saclay University, Versailles, France.
Pignot G; Department of Surgical Oncology 2, Institut Paoli-Calmettes, Marseille, France.
Colombel M; Urology Department, Hospices Civils de Lyon, Lyon, France.; Claude Bernard University, Lyon, France.
Guy L; Urology Department, CHU Clermont-Ferrand and Clermont Auvergne University, Clermont-Ferrand.
Rebillard X; Urology Department, Beausoleil Private Hospital, Montpellier, France.
Savareux L; Urology Auvergne Centre, Private Hospital La Chataigneraie, Beaumont, France.
Roumigue M; Department of Urology, CHU Rangueil IUCT Oncopole Toulouse, Toulouse, France.
Nivet S; VitaDX Company, Rennes, France.
Coutade Saidi M; Anatomo and Cytopathology Department, IUCT Oncopole, Toulouse, France.
Piaton E; Est Pathology Centre, Woman-Mother-Child Hospital, Bron, France.
Radulescu C; Anatomo and Cytopathology Department, Foch Hospital, Suresnes, France.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2022 Mar; Vol. 129 (3), pp. 356-363. Date of Electronic Publication: 2021 Apr 26.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma*/diagnosis
Carcinoma, Transitional Cell*/diagnosis
Urinary Bladder Neoplasms*/pathology
Artificial Intelligence ; Biomarkers, Tumor ; Cystoscopy ; Female ; Humans ; Male ; Prospective Studies ; Sensitivity and Specificity ; Urinary Bladder/pathology ; Urine
Czasopismo naukowe
Tytuł:
A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma.
Autorzy:
Schuettfort VM; Department of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.; Department of Urology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
D'Andrea D; Department of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.
Quhal F; Department of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.; Department of Urology, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
Mostafaei H; Department of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.; Research Center for Evidence Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Laukhtina E; Department of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Mori K; Department of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.; Department of Urology, Jikei University School of Medicine, Tokyo, Japan.
König F; Department of Urology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Rink M; Department of Urology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Abufaraj M; Department of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.; Division of Urology, Department of Special Surgery, Jordan University Hospital, University of Jordan, Amman, Jordan.
Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Centre, Montreal, QC, Canada.
Luzzago S; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Centre, Montreal, QC, Canada.; Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy.
Rouprêt M; Urology, Predictive Onco-Urology, AP-HP, Urology Hôpital Pitié-Salpêtrière, Sorbonne Université, Paris, France.
Enikeev D; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Zimmermann K; Clinic for Urology, Central Military Hospital Koblenz, Koblenz, Germany.
Deuker M; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Centre, Montreal, QC, Canada.; Department of Urology, University Hospital Frankfurt, Frankfurt, Germany.
Moschini M; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
Sari Motlagh R; Department of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.; Men's Health and Reproductive Health Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Grossmann NC; Department of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.; Department of Urology, University Hospital Zurich, Zurich, Switzerland.
Katayama S; Department of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Pradere B; Department of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.; Department of Urology, University Hospital of Tours, Tours, France.
Shariat SF; Department of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.; Division of Urology, Department of Special Surgery, Jordan University Hospital, University of Jordan, Amman, Jordan.; Department of Urology, University Hospital Frankfurt, Frankfurt, Germany.; Department of Urology, Weill Cornell Medical College, New York, NY, USA.; Department of Urology, University of Texas Southwestern, Dallas, TX, USA.; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria.; European Association of Urology Research Foundation, Arnhem, The Netherlands.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2022 Feb; Vol. 129 (2), pp. 182-193. Date of Electronic Publication: 2021 Apr 07.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Transitional Cell*/pathology
Urinary Bladder Neoplasms*/pathology
Biomarkers ; Cystectomy ; Humans ; Prognosis ; Retrospective Studies ; Systemic Inflammatory Response Syndrome/diagnosis ; Systemic Inflammatory Response Syndrome/etiology ; Urinary Bladder/pathology
Czasopismo naukowe
Tytuł:
Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?
Autorzy:
Del Giudice F; Department of, Departments of, Maternal-Infant and Urological Sciences, 'Sapienza' University of Rome, Policlinico Umberto, Hospital, Rome, Italy.; Department of Urology, Stanford University, School of Medicine, Stanford, CA, USA.
Leonardo C; Department of, Departments of, Maternal-Infant and Urological Sciences, 'Sapienza' University of Rome, Policlinico Umberto, Hospital, Rome, Italy.
Simone G; Department of Urology, 'Regina Elena' National Cancer Institute, IRCCS, Rome, Italy.
Pecoraro M; Department of Radiological Sciences, Oncology & Pathology, 'Sapienza' University of Rome, Policlinico Umberto, Hospital, Rome, Italy.
De Berardinis E; Department of, Departments of, Maternal-Infant and Urological Sciences, 'Sapienza' University of Rome, Policlinico Umberto, Hospital, Rome, Italy.
Cipollari S; Department of Radiological Sciences, Oncology & Pathology, 'Sapienza' University of Rome, Policlinico Umberto, Hospital, Rome, Italy.
Flammia S; Department of, Departments of, Maternal-Infant and Urological Sciences, 'Sapienza' University of Rome, Policlinico Umberto, Hospital, Rome, Italy.
Bicchetti M; Department of Radiological Sciences, Oncology & Pathology, 'Sapienza' University of Rome, Policlinico Umberto, Hospital, Rome, Italy.
Busetto GM; Department of, Departments of, Maternal-Infant and Urological Sciences, 'Sapienza' University of Rome, Policlinico Umberto, Hospital, Rome, Italy.
Chung BI; Department of Urology, Stanford University, School of Medicine, Stanford, CA, USA.
Gallucci M; Department of, Departments of, Maternal-Infant and Urological Sciences, 'Sapienza' University of Rome, Policlinico Umberto, Hospital, Rome, Italy.
Catalano C; Department of Radiological Sciences, Oncology & Pathology, 'Sapienza' University of Rome, Policlinico Umberto, Hospital, Rome, Italy.
Panebianco V; Department of Radiological Sciences, Oncology & Pathology, 'Sapienza' University of Rome, Policlinico Umberto, Hospital, Rome, Italy.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2020 Nov; Vol. 126 (5), pp. 610-619. Date of Electronic Publication: 2020 Aug 17.
Typ publikacji:
Journal Article
MeSH Terms:
Urinary Bladder Neoplasms*/diagnostic imaging
Urinary Bladder Neoplasms*/pathology
Urinary Bladder Neoplasms*/surgery
Cystectomy/*methods
Time-to-Treatment/*statistics & numerical data
Aged ; Cystoscopy ; Female ; Humans ; Male ; Middle Aged ; Multiparametric Magnetic Resonance Imaging ; Neoplasm Staging ; Predictive Value of Tests ; Preoperative Care ; Retrospective Studies ; Urinary Bladder/diagnostic imaging ; Urinary Bladder/pathology ; Urinary Bladder/surgery
Czasopismo naukowe
Tytuł:
Combination Bacillus Calmette-Guérin and indoleamine 2,3-dioxygenase 1 inhibitor therapy of murine orthotopic bladder cancer.
Autorzy:
Lee SH; Department of Pharmacy, National University of Singapore, Singapore City, Singapore.
Mahendran R; Department of Surgery, National University of Singapore, Singapore City, Singapore.
Tham SM; Department of Surgery, National University of Singapore, Singapore City, Singapore.; Department of Urology, National University Hospital, Singapore City, Singapore.
Thamboo TP; Department of Pathology, National University Hospital, Singapore City, Singapore.
Kioh DYQ; Department of Pharmacy, National University of Singapore, Singapore City, Singapore.
Tang LWT; Department of Pharmacy, National University of Singapore, Singapore City, Singapore.
Chiong E; Department of Surgery, National University of Singapore, Singapore City, Singapore.; Department of Urology, National University Hospital, Singapore City, Singapore.
Esuvaranathan K; Department of Surgery, National University of Singapore, Singapore City, Singapore.; Department of Urology, National University Hospital, Singapore City, Singapore.
Chan ECY; Department of Pharmacy, National University of Singapore, Singapore City, Singapore.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2020 Nov; Vol. 126 (5), pp. 554-556. Date of Electronic Publication: 2020 Aug 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Acetamides*/pharmacology
Acetamides*/therapeutic use
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
BCG Vaccine*/pharmacology
BCG Vaccine*/therapeutic use
Quinolines*/pharmacology
Quinolines*/therapeutic use
Urinary Bladder Neoplasms*/chemistry
Urinary Bladder Neoplasms*/drug therapy
Indoleamine-Pyrrole 2,3,-Dioxygenase/*antagonists & inhibitors
Animals ; Kynurenine/blood ; Mice ; Neoplasms, Experimental/chemistry ; Neoplasms, Experimental/drug therapy ; Urinary Bladder/chemistry ; Urinary Bladder/drug effects
Czasopismo naukowe
Tytuł:
Randomized controlled trial of intravesical electrical stimulation for underactive bladder.
Autorzy:
Liao L; Department of Urology, China Rehabilitation Research Centre, Rehabilitation School of Capital Medical University, Beijing, China.; University of Health and Rehabilitation Sciences, Qingdao, Shandong, China.
Deng H; Department of Urology, China Rehabilitation Research Centre, Rehabilitation School of Capital Medical University, Beijing, China.; University of Health and Rehabilitation Sciences, Qingdao, Shandong, China.
Chen G; Department of Urology, China Rehabilitation Research Centre, Rehabilitation School of Capital Medical University, Beijing, China.
Chen H; Guangdong Work Injury Rehabilitation Hospital, Guangzhou, Guangdong, China.
Huang M; Guangdong Work Injury Rehabilitation Hospital, Guangzhou, Guangdong, China.
Xie K; Guangzhou First People's Hospital, Guangzhou, Guangdong, China.
Wei X; Guangzhou First People's Hospital, Guangzhou, Guangdong, China.
Xu Z; Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China.
Huang B; Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China.
Chong T; The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, China.
Chen Q; The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, China.
Xiao H; Peking Union Medical College Hospital, Beijing, China.
Huang Z; Peking Union Medical College Hospital, Beijing, China.
Jiang H; The 1st Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Jing H; Department of Urology, China Rehabilitation Research Centre, Rehabilitation School of Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2023 Mar; Vol. 131 (3), pp. 321-329. Date of Electronic Publication: 2022 Oct 02.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Urinary Bladder, Underactive*
Urinary Bladder Diseases*
Humans ; Quality of Life ; Prospective Studies ; Single-Blind Method ; Treatment Outcome ; Electric Stimulation
Czasopismo naukowe
Tytuł:
Longitudinal follow-up and performance validation of an mRNA-based urine test (Xpert Bladder Cancer Monitor ) for surveillance in patients with non-muscle-invasive bladder cancer.
Autorzy:
Cowan B; Urology Associates, Englewood, CO, USA.
Klein E; Idaho Urologic Institute, Meridian, ID, USA.
Jansz K; Jansz Medicine Professional Corp, Burlington, ON, Canada.
Westenfelder K; Five Valleys Urology, Missoula, MT, USA.
Bradford T; Virginia Urology, Richmond, VA, USA.
Peterson C; North Idaho Urology, Coeur d Alene, ID, USA.
Scherr D; Weill Cornell Medicine, New York, NY, USA.
Karsh LI; The Urology Centre of Colorado, Denver, CO, USA.
Egerdie B; Urology Associates/Urology Medical Research, Kitchener, ON, Canada.
Witjes A; Radboud University Medical Centre, Nijmegen, The Netherlands.
Trainer A; Adult and Paediatric Urology, Omaha, NE, USA.
Harris R; UroPartners, Melrose Park, IL, USA.
Goldfarb B; Medical Offices, North Bay, ON, Canada.
Flax S; Urology Clinic, North York, ON, Canada.
Kroeger R; Urology Centre, St. Omaha, NE, USA.
Boyd B; Urology Associates of Savannah, Savannah, GA, USA.
Liao J; VA Palo Alto Health Care System, Palo Alto, CA, USA.
Patel S; Stephenson Cancer Centre, Oklahoma City, OK, USA.
Bridge J; University of Nebraska Medical Centre, Omaha, NE, USA.
Reuter V; MSKCC, New York, NY, USA.
Quigley N; Geneuity Clinical Research Services, Maryville, TN, USA.
Brown S; Cepheid, Sunnyvale, CA, USA.
Zhao S; Cepheid, Sunnyvale, CA, USA.
Satya M; Cepheid, Sunnyvale, CA, USA.
Bates M; Cepheid, Sunnyvale, CA, USA.
Simon IM; Cepheid, Sunnyvale, CA, USA.
Campbell S; Cepheid, Sunnyvale, CA, USA.
Lotan Y; UT Southwestern, Dallas, TX, USA.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2021 Dec; Vol. 128 (6), pp. 713-721. Date of Electronic Publication: 2021 May 05.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study; Validation Study
MeSH Terms:
Neoplasm Recurrence, Local/*diagnosis
Neoplasm Recurrence, Local/*urine
RNA, Messenger/*urine
Urinary Bladder Neoplasms/*diagnosis
Urinary Bladder Neoplasms/*urine
Adult ; Aged ; Aged, 80 and over ; Cystoscopy ; Female ; Follow-Up Studies ; Humans ; In Situ Hybridization, Fluorescence ; Liquid Biopsy ; Longitudinal Studies ; Male ; Middle Aged ; Muscle, Smooth/pathology ; Neoplasm Grading ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local/pathology ; Predictive Value of Tests ; Prospective Studies ; Urinary Bladder/pathology ; Urinary Bladder Neoplasms/pathology ; Urinary Bladder Neoplasms/surgery ; Urine/chemistry ; Urine/cytology
Czasopismo naukowe
Tytuł:
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration.
Autorzy:
Ravi P; Dana-Farber Cancer Institute, Boston, MA, USA.
Pond GR; McMaster University, Hamilton, ON, Canada.
Diamantopoulos LN; Fred Hutchinson Cancer Research Center Seattle, University of Washington, Seattle, WA, USA.; University of Pittsburg Medical Center, Pittsburgh, PA, USA.
Su C; University of Michigan, Ann Arbor, MI, USA.
Alva A; University of Michigan, Ann Arbor, MI, USA.
Jain RK; Moffitt Cancer Center, Tampa, FL, USA.
Skelton WP 4th; Moffitt Cancer Center, Tampa, FL, USA.
Gupta S; University of Utah's Huntsman Cancer Institute, Salt Lake City, UT, USA.
Tward JD; University of Utah's Huntsman Cancer Institute, Salt Lake City, UT, USA.
Olson KM; Mayo Clinic College of Medicine, Scottsdale, AZ, USA.
Singh P; Mayo Clinic College of Medicine, Scottsdale, AZ, USA.
Grunewald CM; Department of Urology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Niegisch G; Department of Urology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Lee JL; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Gallina A; Vita-Salute San Raffaele University, Milan, Italy.
Bandini M; Vita-Salute San Raffaele University, Milan, Italy.
Necchi A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Mossanen M; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.
McGregor BA; Dana-Farber Cancer Institute, Boston, MA, USA.
Curran C; Dana-Farber Cancer Institute, Boston, MA, USA.
Grivas P; Fred Hutchinson Cancer Research Center Seattle, University of Washington, Seattle, WA, USA.
Sonpavde GP; Dana-Farber Cancer Institute, Boston, MA, USA.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2021 Nov; Vol. 128 (5), pp. 607-614. Date of Electronic Publication: 2021 May 18.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Neoplasm Recurrence, Local/*pathology
Urinary Bladder Neoplasms/*drug therapy
Urinary Bladder Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Chemotherapy, Adjuvant ; Cisplatin/administration & dosage ; Cystectomy ; Deoxycytidine/administration & dosage ; Deoxycytidine/analogs & derivatives ; Doxorubicin/administration & dosage ; Female ; Humans ; Internationality ; Kaplan-Meier Estimate ; Male ; Methotrexate/administration & dosage ; Middle Aged ; Muscle, Smooth/pathology ; Neoadjuvant Therapy ; Neoplasm Invasiveness ; Neoplasm Metastasis ; Neoplasm Staging ; Proportional Hazards Models ; Risk Factors ; Time Factors ; Urinary Bladder/pathology ; Urinary Bladder Neoplasms/surgery ; Vinblastine/administration & dosage ; Gemcitabine
SCR Protocol:
M-VAC protocol
Czasopismo naukowe
Tytuł:
Considering non-bladder aetiologies of overactive bladder: a functional neuroimaging study.
Autorzy:
Walter M; Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland.; Department of Urology, University Hospital Basel, University of Basel, Basel, Switzerland.
Leitner L; Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland.
Betschart C; Department of Gynecology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
Engeler DS; Department of Urology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Freund P; Spinal Cord Injury Center, Balgrist University Hospital, University of Zürich, Zürich, Switzerland.; Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.; Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, London, UK.; Department of Neurology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
Kessler TM; Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland.
Kollias S; Department of Neuroradiology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
Liechti MD; Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland.
Scheiner DA; Department of Gynecology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
Michels L; Department of Neuroradiology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
Mehnert U; Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2021 Nov; Vol. 128 (5), pp. 586-597. Date of Electronic Publication: 2021 Mar 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Brain/*diagnostic imaging
Brain/*physiopathology
Urinary Bladder, Overactive/*diagnostic imaging
Urinary Bladder, Overactive/*etiology
Adult ; Case-Control Studies ; Cognition ; Cold Temperature ; Female ; Functional Neuroimaging ; Humans ; Magnetic Resonance Imaging ; Mental Status and Dementia Tests ; Saline Solution ; Surveys and Questionnaires ; Urinary Bladder/diagnostic imaging ; Urinary Bladder/physiopathology ; Urinary Bladder, Overactive/physiopathology ; Urodynamics
Czasopismo naukowe
Tytuł:
The role of prostaglandin and E series prostaglandin receptor type 4 receptors in the development of bladder overactivity in a rat model of chemically induced prostatic inflammation.
Autorzy:
Mizoguchi S; Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Urology, Oita University Graduate School of Medicine, Yufu, Japan.
Wolf-Johnson AS; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Ni J; Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Mori K; Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Urology, Oita University Graduate School of Medicine, Yufu, Japan.
Suzuki T; Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Takaoka E; Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Mimata H; Department of Urology, Oita University Graduate School of Medicine, Yufu, Japan.
DeFranco DB; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Wang Z; Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Birder LA; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Yoshimura N; Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2019 Nov; Vol. 124 (5), pp. 883-891. Date of Electronic Publication: 2019 Jun 26.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Inflammation*/metabolism
Inflammation*/physiopathology
Receptors, Prostaglandin E*/antagonists & inhibitors
Receptors, Prostaglandin E*/metabolism
Urinary Bladder, Overactive*/metabolism
Urinary Bladder, Overactive*/physiopathology
Prostaglandins E/*metabolism
Prostatitis/*metabolism
Animals ; Disease Models, Animal ; Male ; Mucous Membrane/metabolism ; Rats ; Rats, Sprague-Dawley ; Urinary Bladder/metabolism ; Urinary Bladder/physiopathology
Czasopismo naukowe
Tytuł:
British Association of Urological Surgeons (BAUS) and Nurses (BAUN) consensus document: management of the complications of long-term indwelling catheters.
Autorzy:
Reid S; Princess Royal Spinal Injuries Unit, Northern General Hospital, Sheffield, UK.
Brocksom J; Leeds Teaching Hospital, Leeds, UK.
Hamid R; University College London Hospitals and London Spinal Injuries Unit, Stanmore, UK.
Ali A; Pinderfields Hospital, Wakefield, UK.
Thiruchelvam N; Addenbrooke's Hospital, Cambridge, UK.
Sahai A; Guy's and St. Thomas' NHS Foundation Trust, London, UK.
Harding C; Newcastle upon Tyne Hospitals - NHS Foundation Trust, Newcastle, UK.
Biers S; Addenbrooke's Hospital, Cambridge, UK.
Belal M; Queen Elizabeth Hospital, Birmingham, UK.
Barrett R; University College London Hospitals, London, UK.
Taylor J; Clinical Governance Lead, Salford Royal Hospital, Manchester, UK.
Parkinson R; Nottingham University Hospitals NHS Trust, Nottingham, UK.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2021 Dec; Vol. 128 (6), pp. 667-677. Date of Electronic Publication: 2021 May 17.
Typ publikacji:
Journal Article; Practice Guideline; Review
MeSH Terms:
Catheter Obstruction/*etiology
Catheter-Related Infections/*therapy
Catheters, Indwelling/*adverse effects
Urinary Bladder Diseases/*therapy
Urinary Catheters/*adverse effects
Urinary Tract Infections/*therapy
Catheter-Related Infections/etiology ; Consensus ; Humans ; Metaplasia/etiology ; Necrosis/etiology ; Necrosis/prevention & control ; Spasm/etiology ; Therapeutic Irrigation ; Time Factors ; Urethra/pathology ; Urinary Bladder/pathology ; Urinary Bladder Diseases/etiology ; Urinary Tract Infections/etiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies